Medical Imaging Markets: Molecular Imaging

Questions: Discounts, Updates etc.

Pages: 138

Price (Single): $3500

Price (Company): $7000

Publication Date: 2010-07-01

Order Online Now

People that purchased this report also purchased:

Contact LeadDiscovery

  • If you have questions about this report
  • To find out if you qualify for a discount
  • Want a more up to date version
  • Can't find a report that meets your needs
Search all reports

Keywords:

Boolean terms AND, OR, NOT can be used. Phrases should be entered within quotes. For wildcards use an *


Molecular imaging involves the ability to generate images of specific molecules within the body. The versatility of medical imaging modalities is continuing to increase as care givers keep older people alive longer. Age-related diseases such as cancer, stroke and heart disease represent the highest cost burden to health care in developed countries.

 

Medical Imaging Markets: Molecular Imaging offers complete market coverage of world markets for molecular imaging products for the following technologies:

For each of these modalities, the report provides current market size based on revenues to manufacturers of imaging systems used for molecular procedures, as well as forecasts of future revenues.

Interest in and use of the technology has exploded in recent years, thanks to advances in cell biology, biochemical agents, and computer analysis, and serious market watchers in medical imaging industries, as well as those serving or investing in medical imaging companies, will want to keep abreast of this new market. As part of its comprehensive coverage, Medical Imaging Markets: Molecular Imaging includes:

Kalorama looks at the technologies currently used in molecular imaging but also examines novel research areas, such as:

Market forecasts are based on an examination of current market conditions and on investigations into the development of new products by key companies. The market data provide multiple year forecasts for different product segments covered in the report. The information presented in this report is the result of data gathered from company product literature and other corporate brochures and documents, as well as information found in the scientific and trade press. In addition, interviews were conducted with company executives, clinicians and researchers.


Additional Information

Big Players Team Up for Share of $6.6 Billion Molecular Imaging Market, Kalorama Information

The cost-savings associated with early disease detection and clinicians’ demand for better, more accurate diagnostic tools are key drivers for a predicted 5.8% yearly increase in the market for molecular imaging devices. According to a new report by healthcare market research publisher Kalorama Information, this market is expected to reach $6.6 billion by 2014.

Differing from traditional diagnostic tools, molecular imaging devices use biomarkers, which produce finer images that display molecular changes, allowing physicians to pinpoint diseases. Devices include nuclear medicine based PET, which renders metabolic information, and SPECT, which produces anatomical images. These devices are well known for their ability to detect the molecular basis of diseases, including neurological and cardiovascular based diseases. In tumors, they detect chemical signatures that provide an early warning. In addition, advances in these devices have recently helped to identify vulnerable plaque in at-risk cardiac patients. Kalorama notes that combining new molecular contrast agents with traditional diagnostic tools, such us Ultrasound, MRI and CT has enabled physicians to capture specific molecular pathways to track the progress of treatment.

While rapid advances in molecular imaging devices are pushing growth, physicians are even quicker to demand better products with:

“Meeting the growing demand for a better molecular imaging device is a big driver for companies seeking to break into this market,” says Bruce Carlson, publisher of Kalorama Information. “The market could even grow further if physicians’ demands are met and we see a rise in patient confidence, as this could translate into more individuals opting in for these services.”

The adoption of molecular imaging equipment is not exclusive to physicians, according to Kalorama. Pharmaceutical and biotechnology companies are also utilizing molecular imaging equipment, as it allows them to test drug candidates in vivo for mechanisms, disposition and efficacy. The big players, such as Siemens, GE Healthcare, Phillips, and Toshiba are teaming up with contrast media companies to develop the next generation of molecular imaging equipment.

Kalorama Information’s report, Molecular Imaging Markets (Market Intelligence Analysis of Market Opportunities in Molecular Imaging), contains more information on market forecasts, company profiles, and trends in the molecular imaging market. The report is available at: http://www.kaloramainformation.com/Medical-Imaging-Molecular-2613825/.

Table of Contents


TABLE OF CONTENTS

 

1.0 Executive Summary

2.0 Introduction

3.0 Research with Potential

4.0 Markets

5.0 Corporate Profiles

LIST OF EXHIBITS

 

  • Exhibit 1: World Market for Molecular Imaging
  • Exhibit 2: Key Liquid Radionuclides
  • Exhibit 3: Worldwide SPECT Procedures
  • Exhibit 4: US SPECT Procedures
  • Exhibit 5: Worldwide PET Procedures
  • Exhibit 6: US PET Procedures
  • Exhibit 7: Worldwide Molecular CT Procedures
  • Exhibit 8: Worldwide Molecular PET Procedures
  • Exhibit 9: World Medical Market for PET Systems
  • Exhibit 10: US Medical Market for PET Systems
  • Exhibit 11: World Medical Market for PET Systems
  • Exhibit 12: US Medical Market for PET Systems
  • Exhibit 13: Worldwide Medical PET Installed Base
  • Exhibit 14: World Medical Market for SPECT Systems
  • Exhibit 15: US Medical Market for SPECT Systems
  • Exhibit 16: World Medical Market for SPECT Systems
  • Exhibit 17: US Medical Market for SPECT Systems
  • Exhibit 18: Worldwide Medical SPECT Installed Base
  • Exhibit 19: World Medical Market for MRI Molecular Imaging Systems
  • Exhibit 20: US Medical Market for MRI Molecular Imaging Systems
  • Exhibit 21: World Medical Market for CT Molecular Imaging Systems
  • Exhibit 22: US Medical Market for CT Molecular Imaging Systems
  • Exhibit 23: World Medical Market for Ultrasound Molecular Imaging Systems
  • Exhibit 24: US Medical Market for Ultrasound Molecular Imaging Systems
  • Exhibit 25: World Medical Market for PET/CT Imaging Systems
  • Exhibit 26: US Medical Market for PET/CT Imaging Systems
  • Exhibit 27: World Medical Market for SPECT/CT Imaging Systems
  • Exhibit 28: US Medical Market for SPECT/CT Imaging Systems

    • Other users found this report page using the following search terms: market imaging spect medical molecular installed pet base mri markets

    If you can't find a report that meets your needs contact LeadDiscovery. We are one of the few report providers with extensive drug development experience and we frequently use this knowledge to help clients source the most appropriate reports or produce reports for them from scratch.


    Refund and Cancellation Policy: The descriptions of the products and services sold on LeadDiscovery.co.uk are as complete and accurate as possible, and customers are encouraged to read all available information about a product before placing an order. Due to the nature of the information being sold, orders for reports cannot be canceled.